Page 8 of articles about vaccine

Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries

Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.

Home

HealthPress releases

Ceva completes acquisition of IDT veterinary business assets

IDT’s strong range of swine vaccines will strengthen Ceva’s rapidly growing presence in this segment.

Home

HealthPress releases

Zoetis receives EU Commission approval for variation group on Suvaxyn PRRS MLV Vaccine

Reduction of the onset of immunity for fattening pigs, gilts and sows from 28 days to 21 days. Extension of the duration of immunity for gilts and sows from 16 weeks to 26 weeks.

Home

HealthArticle

Serotyping of Actinobacillus pleuropneumoniae field isolates by PCR

A newly produced PCR-based test can help assigning all known App serotypes, which can be used to select the most appropriate vaccine.

Home

HealthPress releases

Pirbright and ViroVet join forces to develop African swine fever antivirals

Commercial vaccines have been estimated to be several years away, so the development of alternative control methods is of critical global importance.

Home

HealthPress releases

MSD launches PORCILIS^® Ery+Parvo+Lepto, a triple-action vaccine with broad protection

New vaccine technology delivers multiple vaccines in one, single injection.

Home

HealthPress releases

Inovio and Plumbline Life Sciences establish animal health collaboration to develop a novel vaccine against ASF

As part of this agreement, Inovio will construct and test the ASF vaccine in small animal models.

Home

5 1

HealthAbstract

First oral vaccination of Eurasian wild boar against ASF virus genotype II

This is, to our knowledge, the first report of a promising vaccine against ASF virus in wild boar by oral administration.

Home

HealthNews

Best-practice guidance for the use of vaccines in animals

EPRUMA publishes new best-practice guidance for the use of vaccines in animals

Home

HealthPress releases

The World’s first Plant-derived Porcine Marker Vaccine from Korea

HERBAVAC^TM CSF Green Marker is the World’s First plant-derived recombinant subunit vaccine against Classical Swine Fever Virus and can Differentiate Infected from Vaccinated Animals.

Home

HealthNews

European law on veterinary medicines: what’s new?

The Federation of Veterinarians of Europe has just published an infographic on the new legislation on veterinary medicines.

Home

HealthNews

UK: Update on veterinary medicine supply in a no deal EU Exit

Further details of the preparations underway to minimise disruption of the supply of veterinary medicines in a no deal EU Exit.

Home

HealthPress releases

Boehringer Ingelheim launches first veterinary vaccines produced in China

The first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine market.

Home

Image 1. Nasal discharge + fever - Swine flu.

HealthArticle

Swine influenza: doubts about its control on the farm

The author presents a review of the current situation of influenza in pigs to end with his doubts and comments on the effectiveness of control measures on the farm.

Home

HealthAbstract

Vaccination of 1-day-old pigs with a PRRSV modified live attenuated virus vaccine is able to overcome maternal immunity

The efficacy of the attenuated PRRSV-1 vaccine in 1-day-old pigs seropositive to PRRSV prior to a PRRSV-1 challenge was demonstrated by improvement of clinical, virological and immunological variables.

Home

Fig 2. Effect of traditional and heterologous prime-boost vaccination regimens on the breadth of the anti-H3N2 antibody response. European and North American H3N2 SwIV strains are indicated by different flags. Sera collected 14 days after the second vaccination were tested against 15 antigenically distinct viruses including the vaccine strains. The numbers represent the number of viruses against which HI antibody titers were ≥ 40.

3 3

HealthArticle

A different take on swine influenza vaccination

Influenza researchers are trying to stimulate antibody responses towards parts of the HA that are the least variable from strain to strain. One approach that seems promising is choosing two antigenically very different strains within the H1 or H3 subtype for the primary and subsequent booster vaccinations.